ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,456Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 807

$684K Total Retail Price of All Prescriptions

Rank: 41 out of 807

514 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 514 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 514 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 10,947 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LEVOTHYROXINE SODIUM 808 688 1 3
PRAVASTATIN SODIUM 500 393 2 21
LISINOPRIL 490 427 3 2
OMEPRAZOLE 449 372 4 4
FUROSEMIDE 440 424 5 6
SIMVASTATIN 364 328 6 1
GABAPENTIN 360 248 7 16
ATENOLOL 351 317 8 7
WARFARIN SODIUM 297 278 9 10
ALLOPURINOL 277 266 10 26
METOPROLOL TARTRATE 274 242 11 8
METFORMIN HCL 270 225 12 12
AMLODIPINE BESYLATE 264 215 13 5
ATORVASTATIN CALCIUM 261 239 14 11
LOSARTAN POTASSIUM 250 231 15 14
SPIRONOLACTONE 227 206 16 48
HYDROCODONE-ACETAMINOPHEN 215 132 S3 17 15
METOPROLOL SUCCINATE 212 189 18 13
POTASSIUM CHLORIDE 195 152 19 18
ALENDRONATE SODIUM 191 151 20 20
HYDROCHLOROTHIAZIDE 176 145 21 9
RANITIDINE HCL 145 136 22 34
VITAMIN D2 140 116 23 133
LISINOPRIL-HYDROCHLOROTHIAZIDE 139 103 24 28
ZOLPIDEM TARTRATE 116 77 25 23
PANTOPRAZOLE SODIUM 103 79 26 44
GLIPIZIDE 98 89 27 58
AMITRIPTYLINE HCL 93 66 R 28 71
TRAZODONE HCL 93 70 28 25
PROAIR HFA 92 57 30 43
OXYCODONE-ACETAMINOPHEN 90 53 S2 31 56
CRESTOR 90 63 31 32
LOVASTATIN 83 83 33 39
LANTUS SOLOSTAR 82 65 34 42
CLOPIDOGREL 80 65 35 47
ACETAMINOPHEN-CODEINE 79 65 S3 36 93
TAMSULOSIN HCL 76 76 37 27
LIPITOR 73 72 38 100
ISOSORBIDE MONONITRATE ER 72 66 39 36
DIGOXIN 72 72 39 41
PEN NEEDLE 69 51 41 63
CITALOPRAM HBR 68 36 42 17
FLUOXETINE HCL 67 55 43 52
CHLORTHALIDONE 63 60 44 99
CYCLOBENZAPRINE HCL 62 16 R 45 88
SPIRONOLACTONE-HCTZ 61 56 46 180
ENALAPRIL MALEATE 61 61 46 110
PLAVIX 60 49 48 60
NITROSTAT 58 49 49 104
ROPINIROLE HCL 56 52 50 95
FLOVENT HFA 55 33 51 158
PREDNISONE 55 44 51 24
FENTANYL 55 28 S2 51 65
KLOR-CON 10 53 41 54 81
PAROXETINE HCL 53 48 54 49
DIOVAN 50 40 56 46
LOSARTAN-HYDROCHLOROTHIAZIDE 50 44 56 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.